These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9261254)

  • 21. Angiotensin II inhibits interleukin-1 beta-induced nitric oxide production in cultured rat mesangial cells.
    Kihara M; Yabana M; Toya Y; Kobayashi S; Fujita T; Iwamoto T; Ishigami T; Umemura S
    Kidney Int; 1999 Apr; 55(4):1277-83. PubMed ID: 10200991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
    Cox SL; Story DF; Ziogas J
    Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
    Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
    Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of peroxisome proliferator-activated receptor-γ by angiotensin II via transforming growth factor-β1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells.
    Subramanian V; Golledge J; Heywood EB; Bruemmer D; Daugherty A
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):397-405. PubMed ID: 22095985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
    Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade.
    Hafizi S; Chester AH; Allen SP; Morgan K; Yacoub MH
    Coron Artery Dis; 1998; 9(4):167-75. PubMed ID: 9649922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice.
    Ruiz-Ortega M; Lorenzo O; Rupérez M; Suzuki Y; Egido J
    Nephrol Dial Transplant; 2001; 16 Suppl 1():27-33. PubMed ID: 11369817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
    Haxsen V; Adam-Stitah S; Ritz E; Wagner J
    Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases.
    Touyz RM; Deng LY; He G; Wu XH; Schiffrin EL
    J Hypertens; 1999 Jul; 17(7):907-16. PubMed ID: 10419063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A long-term receptor stimulation is requisite for angiotensin II-dependent DNA synthesis in vascular smooth muscle cells from spontaneously hypertensive rats.
    Itazaki K; Hara M; Itoh N; Fujimoto M
    Eur J Pharmacol; 1995 Nov; 291(3):417-25. PubMed ID: 8719428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells.
    Saward L; Zahradka P
    J Mol Cell Cardiol; 1996 Mar; 28(3):499-506. PubMed ID: 9011633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
    Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
    J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.
    Cox SL; Ben A; Story DF; Ziogas J
    Br J Pharmacol; 1995 Mar; 114(5):1057-63. PubMed ID: 7780640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells.
    Ko Y; Görg A; Appenheimer M; Wieczorek AJ; Düsing R; Vetter H; Sachinidis A
    Eur J Pharmacol; 1992 Oct; 227(2):215-9. PubMed ID: 1426030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors.
    Shimizu-Hirota R; Sasamura H; Mifune M; Nakaya H; Kuroda M; Hayashi M; Saruta T
    J Am Soc Nephrol; 2001 Dec; 12(12):2609-2615. PubMed ID: 11729229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of AT2 receptor on expression of AT1 and TGF-beta receptors in VSMCs from SHR.
    Su JZ; Fukuda N; Jin XQ; Lai YM; Suzuki R; Tahira Y; Takagi H; Ikeda Y; Kanmatsuse K; Miyazaki H
    Hypertension; 2002 Dec; 40(6):853-8. PubMed ID: 12468569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.
    Freeman EJ; Tallant EA
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):543-8. PubMed ID: 7998990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.